We are live on
!
Find out more
AACP
Advantage Alpha Capital Partners Portfolio holdings
AUM
$332M
1-Year Est. Return
12.78%
This Fund
S&P 500
This Quarter
Est. Return
+8.8%
1 Year Est. Return
+12.78%
3 Year Est. Return
+79.23%
5 Year Est. Return
+110.24%
10 Year Est. Return
–
AUM
$332M
AUM Growth
-$39.1M
(-11%)
Cap. Flow
-$62.1M
Cap. Flow
% of AUM
-18.72%
Top 10 Holdings %
Top 10 Hldgs %
18.07%
Holding
140
New
21
Increased
26
Reduced
83
Closed
10
Top Buys
| 1 |
Harrow
HROW
|
+$4.2M |
| 2 |
Transcat
TRNS
|
+$3.76M |
| 3 |
Ryman Hospitality Properties
RHP
|
+$3.16M |
| 4 |
Universal Technical Institute
UTI
|
+$3M |
| 5 |
WAY
Waystar Holding Corp
WAY
|
+$2.93M |
Top Sells
| 1 |
Ceco Environmental
CECO
|
+$6.18M |
| 2 |
SharkNinja
SN
|
+$4.32M |
| 3 |
Workiva
WK
|
+$4.31M |
| 4 |
Magnite
MGNI
|
+$4.3M |
| 5 |
FTAI Aviation
FTAI
|
+$4.01M |
Sector Composition
| 1 | Industrials | 35.84% |
| 2 | Technology | 18.8% |
| 3 | Healthcare | 15.52% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Financials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Riot Platforms
RIOT
$7.63B
| $647K | 0.19% |
33,990
-6,912
| -17% | -$95.7K |
|
102
Halozyme
HALO
$9.03B
| $621K | 0.19% |
8,466
-1,567
| -16% | -$104K |
|
103
ANI Pharmaceuticals
ANIP
$1.84B
| $582K | 0.18% |
6,354
-1,598
| -20% | -$130K |
|
104
Veracyte
VCYT
$4.59B
| $544K | 0.16% |
15,859
-3,264
| -17% | -$93.6K |
|
105
ADMA Biologics
ADMA
$2.08B
| $498K | 0.15% |
33,943
-9,875
| -23% | -$169K |
|
106
CleanSpark
CLSK
$3.17B
| $434K | 0.13% |
29,926
-6,827
| -19% | -$77K |
|
107
Alkermes
ALKS
$8.65B
| $424K | 0.13% |
14,122
-3,200
| -18% | -$90.2K |
|
108
Krystal Biotech
KRYS
$10.7B
| $421K | 0.13% |
2,387
-507
| -18% | -$75.9K |
|
109
TG Therapeutics
TGTX
$8.42B
| $419K | 0.13% |
11,598
-2,716
| -19% | -$89.5K |
|
110
Arrowhead Research
ARWR
$10.4B
| $406K | 0.12% |
11,780
-1,158
| -9% | -$25.5K |
|
111
Emergent Biosolutions
EBS
$413M
| $405K | 0.12% |
+45,936
| New | +$357K |
|
112
Stoke Therapeutics
STOK
$1.83B
| $398K | 0.12% |
16,941
-947
| -5% | -$16.2K |
|
113
MiMedx Group
MDXG
$608M
| $396K | 0.12% |
56,727
-9,397
| -14% | -$65.3K |
|
114
Protagonist Therapeutics
PTGX
$8.35B
| $386K | 0.12% |
5,804
-1,168
| -17% | -$66.4K |
|
115
Kura Oncology
KURA
$969M
| $380K | 0.11% |
+42,958
| New | +$306K |
|
116
Rigel Pharmaceuticals
RIGL
$764M
| $334K | 0.1% |
+11,804
| New | +$353K |
|
117
CareDx
CDNA
$1.49B
| $308K | 0.09% |
+21,164
| New | +$302K |
|
118
Keros Therapeutics
KROS
$220M
| $286K | 0.09% |
+18,059
| New | +$267K |
|
|
HUT
119
Hut 8
HUT
$11.2B
| $275K | 0.08% |
+7,898
| New | +$201K |
|
120
Catalyst Pharmaceutical
CPRX
$3.85B
| $262K | 0.08% |
13,313
-2,887
| -18% | -$59.4K |
|
|
DVAX
121
DELISTED
Dynavax Technologies
DVAX
| $257K | 0.08% |
25,892
-5,266
| -17% | -$54.8K |
|
122
The Bancorp
TBBK
$2.77B
| $242K | 0.07% |
+3,226
| New | +$225K |
|
123
Aurinia Pharmaceuticals
AUPH
$2.06B
| $230K | 0.07% |
20,849
-3,230
| -13% | -$35.3K |
|
124
Acadia Pharmaceuticals
ACAD
$4.37B
| $227K | 0.07% |
10,623
-2,020
| -16% | -$47.8K |
|
125
Marathon Digital Holdings
MARA
$4.65B
| $221K | 0.07% |
12,094
-2,975
| -20% | -$50.1K |
|
Similar funds
CPA
PAWA
EE
GB
SC
SFG
PA
BCCM